As Vachette continues to lead the charge against Anthem’s misguided rate adjustments for pathology and lab services in several states throughout the country, we’re fielding more questions about what options labs facing these cuts truly have. Recently, Vachette CEO Mick Raich and VP of Client Services Ann Lambrix, spoke with Laboratory Economics Publisher Jondavid Klipp to examine the potential scope and overall impact of these cuts.
A full copy of that article is available via the link below. Those who want to view the full May 2019 edition may do so by subscribing here.
Working to determine a viable path forward for your group? Reach out to us at 517-486-4262 to discuss options if your group is notified these reductions will be impacting you.